Home/Stocks/Consumer Non-Cyclicals

Cranswick PLC

CWK.L·Consumer Non-Cyclicals·Market Cap £2.7b
Rank #123 of 280
Quantitative Model · 280 Stocks Analysed
£49.85
+0.61% YTD
52W: £47.75 - £58.10

Factor Analysis Summary

Editorial assessment generated from Cranswick PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Cranswick PLC (CWK.L) currently holds an overall rank of #123 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include asset efficiency, where it demonstrates highly efficient capital deployment, converting assets into revenue and returns effectively, and solvency (debt/equity 0.2), where it demonstrates a sound financial footing with manageable debt levels and adequate interest coverage.

Areas requiring attention include valuation (P/E 17.2, dividend yield 391.3%), where the stock appears richly priced on forward earnings and cash flow metrics, as well as technical (RSI 42.7), where bearish technical positioning with price trading below key trend indicators.

Within the Consumer Non-Cyclicals sector, Cranswick PLC sits at composite rank #123, trailing the Consumer Non-Cyclicals peer average (rank 53). It ranks behind all 6 tracked Consumer Non-Cyclicals peers in our model.

The composite profile is weighed down by 4 below-average factor scores, with valuation (rank 249/280) representing the most significant drag on its #123 overall standing.

Strongest Factors

  • Asset Efficiency — Rank 6/280 (top quartile)
  • Solvency — Rank 93/280 (above average)
  • Market Trading — Rank 122/280 (middle of the pack)

Weakest Factors

  • Valuation — Rank 249/280 (below average)
  • Technical — Rank 247/280 (below average)

Score Analysis

Cranswick PLC is ranked #123 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

155/280
Average Score
Liquidity
Weak194/280
Valuation
Weak249/280
Profitability
Weak174/280
Solvency
Good93/280
Asset Efficiency
Excellent6/280
Mkt Trading
Fair122/280
Technical
Weak247/280

1. Liquidity

Score: 194/280

How liquid is CWK and can it meet its short-term obligations?

2/6
liquidity criteria met
✓
Quick Ratio1.13x
Range: 0.8 - 1.3Rank 51/280
✓
Current Ratio1.76x
Range: 1.2 - 1.8Rank 92/280
✗
TTM Operating Cash Flow0.73x
Range: 0.8 - 1.5Rank 70/280
–
Liquidity Coverage RatioN/A
Range: N/A
✗
Intangible Asset Ratio0.00x
Range: 5 - 20Rank 168/280
✗
Cash-to-Debt Ratio0.05x
Range: 0.4 - 1.2Rank 228/280

Key Liquidity Metrics

Quick Ratio
1.13x
Sector: 0.8 - 1.3
Current Ratio
1.76x
Sector: 1.2 - 1.8

Overall Liquidity Rank

Rank within universe#194/280
Best (1)Worst (280)

2. Valuation

Score: 249/280

Is CWK undervalued compared to its peers and fair value metrics?

5/7
valuation criteria met
✗
FY27e P/E14.6x
Range: 15x - 28xRank 155/280
✓
FY26e P/E15.7x
Range: 15x - 28xRank 146/280
✗
FY27e Net Div Yld (%)2.39%
Range: 2.5 - 6.5Rank 160/280
✓
Div Payout Ratio38.47%
Range: 35 - 65Rank 100/280
✓
Current EV/EBITDA9.0x
Range: 8.0x - 13.0xRank 154/280
✓
Current P/TBV3.20x
Range: 1.5x - 4.5xRank 155/280
✓
Current P/B2.56x
Range: 1.5x - 4.5xRank 191/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
17.2x
FY26e P/E
Forward estimate
15.7x
FY27e P/E
Forward estimate
14.6x
Current P/B
Price-to-Book
2.56x
Current P/TBV
Tangible Book Value
3.20x
Current EV/EBITDA
Enterprise Value
9.0x
FY26e EV/EBITDA
Forward estimate
8.0x
FY27e EV/EBITDA
Forward estimate
7.9x

Dividend

CWK pays a dividend yield of 391.34%.

Current Yield
391.34%
FY27e Net Div Yield
2.39%
FY26e Gross DPS
1.088
FY27e Gross DPS
1.192

Dividend Per Share Forecast

3. Profitability

Score: 174/280

How profitable is CWK relative to its peers?

3/7
profitability criteria met
✓
TTM Profit Margin5.3%
Range: 5 - 11Rank 194/280
✗
T12 FCF Margin1.7%
Range: 8 - 15Rank 42/280
✓
FY27e RoE14.7%
Range: 8 - 20Rank 122/280
✓
FY26 EPS Growth5.9%
Range: 3 - 8Rank 131/280
✗
FY27e EPS Growth14.1%
Range: 4 - 8Rank 145/280
–
NIMN/A
Range: N/A
–
Expense RatioN/A
Range: 65 - 78
TTM Profit Margin
5.3%
Current RoCE
15.2%
FY27e RoE
14.7%
T12 FCF Margin
1.7%

EPS Growth

4. Solvency

Score: 93/280

How strong is CWK's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt0.23x
Range: 0.3x - 0.7xRank 99/280
–
Interest Coverage RatioRank 102
Range: 4x - 10xRank 102/280
✗
Net Leverage Ratio0.29x
Range: 1.0x - 2.0xRank 45/280
–
Altman Z-Score (Manufacturing)8.38
Range: <1.10 - >2.60Rank 87/280
–
Z-Score (Non Manufacturing)Rank 73
Range: <1.10 - >2.60Rank 73/280
–
CapAdeq Ratio Tier1N/A
Range: N/A

Key Solvency Metrics

Debt/Eqt
0.23x
Net Leverage Ratio
0.29x
Interest Coverage
Rank 102
T12 FCF Margin
1.7%

Altman Z-Score

8.38
Safe Zone
01.812.995+

5. Asset Efficiency

Score: 6/280

How efficiently does CWK deploy its assets and intellectual capital?

0/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: N/A
✗
TTM Asset Turnover Ratio1.82x
Range: 0.8x - 1.5xRank 13/280
✗
TTM CAPEX/Sales5.6%
Range: 2 - 5Rank 83/280
✗
Working Capital Turnover11.56x
Range: 4x - 10xRank 37/280
–
R&D/Sales FY27eN/A
Range: 1.0 - 3.0

Overall Asset Efficiency Rank

Rank within sector peers#6/280
Best (1)Worst (280)

6. Market Trading

Score: 122/280

How liquid and actively traded is CWK?

1/2
market trading criteria met
✗
Intraday Sentiment (%)79.0%
Range: 30 - 70Rank 50/280
–
10D-Avg v/s 3M-Avg Vol161%
Range: N/ARank 50/280
✓
Avg Directional Index 30D13.0
Range: 010 - 35Rank 258/280
–
Parabolic SAR4925.00
Range: N/ARank 17/280
–
Stock Rating RankRank 100
Range: N/ARank 100/280
Market Cap
£2,705,753,411
Enterprise Value
£2,949,485,406

Trading Volume

7. Technical

Score: 247/280

What do the technical indicators say about CWK?

0/5
technical criteria met
–
CMP v/s 52-WH-14.2%
£58.10£47.75
-14.2%CMP: £49.85
Range: N/ARank 164/280
–
CMP v/s 52-WL4.4%
£58.10£47.75
+4.4%CMP: £49.85
Range: N/ARank 24/280
–
RSI 14D42.7
042.7 - Bearish100
Range: N/ARank 50/280
–
MA50 - MA200Bearish
£51.81-1.14£52.95
Range: N/ARank 263/280
–
MACD Rank1.84
Death Cross
MACD: 1.84
Range: N/ARank 100/280

RSI (14 Day)

42.7
Bearish
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£51.81
200 SMA£52.95
SignalDeath Cross (Bearish)
MACD1.84

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does CWK compare to other Consumer Non-Cyclicals stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
CWK#12319424917493122247
ULVR.L#8131197141224108178
ANEA.L#23897815223152141
CCH.L#6111922615514170130
IMB.L#7117271110229107261
PRN.L#7484163274143268202
DGE.L#8148177162198137115
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for Cranswick PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.